Advertisement

Topics

Cannabinoid Drugs Company Raises €300M in Public Offering

09:34 EDT 8 Oct 2018 | Labiotech.eu

GW Pharmaceuticals, a British biotech developing cannabinoid drugs, is on a high after a successful €300M public offering on the Nasdaq Stock Market. The company announced the public offering swiftly after its lead cannabinoid drug, Epidiolex, made history by being ...

The post Cannabinoid Drugs Company Raises €300M in Public Offering appeared first on Labiotech.eu.

Original Article: Cannabinoid Drugs Company Raises €300M in Public Offering

NEXT ARTICLE

More From BioPortfolio on "Cannabinoid Drugs Company Raises €300M in Public Offering"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...